Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Change in Cash (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Change in Cash for 4 consecutive years, with $486.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash rose 171.58% year-over-year to $486.0 million, compared with a TTM value of $1.6 billion through Dec 2025, up 319.38%, and an annual FY2025 reading of $1.6 billion, up 319.38% over the prior year.
  • Change in Cash was $486.0 million for Q4 2025 at GE HealthCare Technologies, up from $264.0 million in the prior quarter.
  • Across five years, Change in Cash topped out at $1.6 billion in Q3 2024 and bottomed at -$679.0 million in Q4 2024.
  • Average Change in Cash over 4 years is $247.2 million, with a median of $72.5 million recorded in 2023.
  • Peak annual rise in Change in Cash hit 1926.92% in 2023, while the deepest fall reached 1720.83% in 2023.
  • Year by year, Change in Cash stood at $947.0 million in 2022, then crashed by 90.92% to $86.0 million in 2023, then crashed by 889.53% to -$679.0 million in 2024, then skyrocketed by 171.58% to $486.0 million in 2025.
  • Business Quant data shows Change in Cash for GEHC at $486.0 million in Q4 2025, $264.0 million in Q3 2025, and $1.3 billion in Q2 2025.